[Lipid peroxidation and antioxidative protection in patients with coronary heart disease]

Insights

Patients with severe coronary heart disease (CHD) exhibit higher lipid peroxidation products (LPP) and lower antioxidant activity. These markers correlate with lipid composition and homocysteine in stable CHD.

Area of Science:

  • Biochemistry
  • Cardiology
  • Clinical Chemistry

Background:

  • Coronary heart disease (CHD) involves complex biochemical alterations.
  • Lipid peroxidation products (LPP) and oxidative stress are implicated in CHD pathogenesis.
  • Assessing antioxidant system activity is crucial for understanding disease severity.

Purpose of the Study:

  • To investigate the relationship between lipid profiles, LPP, homocysteine, and antioxidant enzyme activity in CHD patients.
  • To differentiate biochemical markers between functional classes of angina (FC II and FC III).

Main Methods:

  • Measurement of total cholesterol, HDL, LDL, and LPP (dienic conjugates, TBA-reactive compounds) in blood samples.
  • Quantification of plasma homocysteine and erythrocyte antioxidant enzyme activities (superoxide dismutase, glutathione peroxidase).
  • Assessment of plasma ceruloplasmin/transferrin antioxidant system.

Main Results:

  • Patients with FC III angina showed significantly elevated LPP levels compared to FC II angina or healthy subjects.
  • Lower activity of tissue and plasma antioxidant systems was observed in FC III angina patients.
  • Stable CHD patients demonstrated correlations between lipid composition, LPP, homocysteine, and antioxidant enzyme activity.

Conclusions:

  • Increased LPP and reduced antioxidant capacity are associated with more severe angina in CHD.
  • Biochemical markers including lipids, LPP, homocysteine, and antioxidant enzymes are interconnected in stable CHD.
  • These findings highlight the role of oxidative stress and lipid metabolism in CHD progression.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...